Infectious Diseases Society of America: “Monoclonal Antibodies”.
The New England Journal of Medicine: “Subcutaneous REGEN-COV antibody combination for the prevention of Covid-19.”
William Fales, MD, Medical Director, Michigan Department of Health and Human Services, Department of EMS and Trauma.
Lindsay Petty, MD, Infectious Disease Physician, University of Michigan.
Eli Lilly: “Emergency Use Authorization (EUA) for the treatment of COVID-19.”
FDA: “Emergency Use Authorization (EUA) for Bamlanivimab 700 mg IV Center for Drug Evaluation and Research (CDER) Memorandum on Fact Sheet Update.”
David Wohl, MD, Infectious Disease Expert, University of North Carolina.
CDC: “People with certain diseases”.
Regeneron: “REGEN-COV for COVID-19: Emergency Permit (EUA).”
Comments are closed.